Skip to main content

EOLS

Evolus, Inc.

Company with tickers: EOLS

CIK
1570562
CUSIP
30052C107
Shares Outstanding
65,854,751
13F Activity (30d)
8 filings 7 filers
Price
$6.63
Market Cap
$436.62M
P/E Ratio
-8.29
EPS (Diluted)
$-0.80
52W High
$10.20
52W Low
$3.86

Daily candlestick prices with configurable technical indicators (moving averages, Bollinger Bands, RSI, MACD) and event bullets for 10-K, 10-Q, Form 4 and earnings dates. Price data syncs automatically from Yahoo Finance.

Latest guidance from the 8-K filed May 4, 2026
Metric Period Guided Actual
Total net revenues full-year 2026 $327M – $337M
Adjusted gross profit margin full-year 2026 65.5% – 67%
Non-GAAP operating expenses full-year 2026 $210M – $216M
Evolysse® and Estyme® injectable HA gels revenue contribution as full-year 2026 10% – 12%
1 Down Day

Price & Indicators

Drag to pan · scroll to zoom

Performance

5D 20D 120D MTD YTD
EOLS -1.0% +0.9% -7.8% +1.1% -0.3%
SPY +1.8% +1.6% +9.6% -0.8% +10.0%
vs SPY -2.8% -0.7% -17.4% +1.9% -10.3%
Close
$6.63
Open
$6.75
Day Range
$6.62 — $6.89
52W High
$10.20
52W Low
$3.86
Avg Vol (30d)
825K
Short Interest
6.1M · 8.2d
Short Vol % (latest)
19%
Last Earnings
2026-05-04
Latest Filing
Data Range
2020-01-02 — 2026-06-16